PRESS RELEASE published on 06/13/2024 at 19:48, 2 years 2 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma a passé avec succès la réunion pré-IND avec la FDA pour une étude clinique de phase 2b/3 évaluant CER-001 dans le traitement de patients atteints de sepsis. La société se prépare à déposer une demande d’IND pour lancer l'étude clinique FDA ABIONYX Pharma Sepsis CER-001 Réunion Pré-IND
PRESS RELEASE published on 06/13/2024 at 19:48, 2 years 2 months ago Inside Information / Other news releases ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
PRESS RELEASE published on 06/13/2024 at 19:35, 2 years 2 months ago GTT : Descriptif du programme de rachat d'actions Programme de rachat d'actions de GTT approuvé par l'assemblée générale mixte des actionnaires le 12 juin 2024. Objectifs, montant maximum des fonds et durée du programme détaillés Rachat D'actions Assemblée Générale Mixte GTT Autorisation Montant Maximum Des Fonds
PRESS RELEASE published on 06/13/2024 at 19:35, 2 years 2 months ago GTT : Main terms and conditions of the share buy-back programme GTT announces share buy-back programme with maximum purchase price of €190 per share and maximum amount of €704,488,650, allowing for various objectives including employee stock allocation and liquidity improvement Share Buy-back GTT Liquidity Improvement Maximum Purchase Price Employee Stock Allocation
PRESS RELEASE published on 06/13/2024 at 19:30, 2 years 2 months ago ThriveSparrow Launches Action Plans and AI-Driven Employee Sentiment Analysis to Enhance Employee Engagement ThriveSparrow launches Action Plans for enhanced employee feedback, leveraging AI for sentiment analysis and disrupting traditional performance reviews to boost engagement and performance AI-driven ThriveSparrow Employee Feedback Action Plans Performance Reviews
PRESS RELEASE published on 06/13/2024 at 19:30, 2 years 2 months ago SWTHZ (SweatHouz) Appoints Dr. Susanna Søberg, PhD as Lead Science and Education Advisor SWTHZ appoints Dr. Susanna Søberg, renowned in heat and cold therapy, to its Medical Advisory Board. Expansion plans include 100 new locations in 12 months Expansion Contrast Therapy SWTHZ Dr. Susanna Søberg Boutique Wellness
PRESS RELEASE published on 06/13/2024 at 19:23, 2 years 2 months ago GEVELOT S.A.: COMMUNIQUE MISE EN OEUVRE PROGRAMME RACHAT ACTIONS 2024 Gévelot S.A. met en œuvre un programme de rachat d'actions limité à 10 % du Capital, correspondant à 75 207 actions, avec un coût financier maximum de 18 000 K€. Objectif : rachat en vue d'annulation sur décision du Conseil d'Administration. Validité jusqu'au 13 décembre 2025 Rachat D'actions Conseil D'administration Programme GEVELOT S.A. Annulation
PRESS RELEASE published on 06/13/2024 at 19:23, 2 years 2 months ago GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM GEVELOT SA's Board of Directors implements a share buyback program, authorizing the repurchase of shares for cancellation with specific financial limits until December 13, 2025 Capital Euronext Share Buyback Program GEVELOT SA Financial Cost
PRESS RELEASE published on 06/13/2024 at 19:22, 2 years 2 months ago GEVELOT S.A.: COMMUNIQUE MISE EN OEUVRE PROGRAMME RACHAT ACTIONS 2024 GEVELOT S.A. met en oeuvre son programme de rachat d'actions limité à 10% du capital pour un coût financier maximum de 18 000 K€ jusqu'au 13 décembre 2025 Rachat D'actions Euronext Assemblée Générale Mixte Programme GEVELOT S.A.
PRESS RELEASE published on 06/13/2024 at 19:22, 2 years 2 months ago GEVELOT S.A.: CGM 2024 PRESS RELEASE IMPLEMENTATION OF A SHARES BUY BACK PROGRAM GEVELOT S.A. announces the implementation of a shares buyback program to repurchase shares for cancellation, in accordance with the Ninth Extraordinary Resolution. The buyback program is limited to 10% of the capital with a maximum financial cost set at €18,000K Capital Repurchase GEVELOT S.A. Shares Buyback Program Financial Cost
Published on 08/22/2026 at 05:50, 1 day 2 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 1 day 3 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 1 day 8 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 1 day 9 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 1 day 9 hours ago Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott
Published on 08/21/2026 at 19:36, 1 day 13 hours ago EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 1 day 13 hours ago EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 1 day 14 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 1 day 15 hours ago EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 1 day 16 hours ago BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
Published on 08/18/2026 at 18:00, 4 days 14 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 4 days 14 hours ago Mise à disposition du rapport financier annuel 2025-26